News

AIB has raised $750 million (€666 million) in funding through a new bond. The senior non-preferred bond was offered to investors at an interest rate of 5.32 per cent. AIB said the bond allowed ...
AIB’s financial performance was better than expected in the first quarter of the year, its chief executive said on Thursday, despite fears that Trump administration policies will hit global ...
AIB has raised $750m in funding through a new bond, which offered investors an interest rate of 5.32%. The bank said demand for the bond was high as it received orders worth more than eight times ...
AIB Group Plc shareholders voted to buy back €1.2 billion ($1.4 billion) worth of shares from the Irish state, putting the lender on the verge of full private ownership. Shareholders voted 97% ...
AIB Group Plc’s board will proceed with a €1.2 billion ($1.4 billion) share buyback from the Irish state, after shareholders approved the deal that will put the bank on the brink of full ...
If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. A week ago, Beats debuted its new Beats Pill Navy Blue and Blush Pink colors.
AIB shareholders have voted decisively to buy back about €1.2bn worth of shares from the State, moving the bank closer to full private ownership. In a vote taken at its annual general meeting at ...
Government’s stake in the bank now stands at just 3.3pc An AIB branch. Photo: Bloomberg AIB has bought a €1.2bn portion of the State's remaining shares in the bank - representing 8.2pc of its ...
The Government is on track to sell its final shares in AIB within months after the bank proceeded with a buyback of €1.2 billion of taxpayers’ shares. A transaction had looked doubtful in ...
THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED AS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE MARKET ABUSE REGULATION (EU) 596/2014 ("MAR") LONDON, May ...
after the drugmaker reported positive results from a late-stage trial of a GLP-1 treatment for Type 2 diabetes and obesity in pill form. The last time the stock rose as much was June 29 ...